Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploration of gene expression profiles and immune microenvironment between high and low tumor mutation burden groups in prostate cancer
Cheng Luo, Junxing Chen, Lingwu Chen
International Immunopharmacology (2020) Vol. 86, pp. 106709-106709
Closed Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

Tumor Mutational Burden for Predicting Prognosis and Therapy Outcome of Hepatocellular Carcinoma
Daniela Gabbia, Sara De Martin
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3441-3441
Open Access | Times Cited: 22
Tumor Mutational Burden from Circulating Tumor DNA Predicts Recurrence of Hepatocellular Carcinoma After Resection: An Emerging Biomarker for Surveillance
Chase J. Wehrle, Hanna Hong, Suneel D. Kamath, et al.
Annals of Surgery (2024)
Closed Access | Times Cited: 8
Establishment of cancer-associated fibroblasts-related subtypes and prognostic index for prostate cancer through single-cell and bulk RNA transcriptome
Youliang Qian, Dechao Feng, Jie Wang, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Comprehensive analysis of tumour mutation burden and the immune microenvironment in hepatocellular carcinoma
Fucun Xie, Yi Bai, Xu Yang, et al.
International Immunopharmacology (2020) Vol. 89, pp. 107135-107135
Open Access | Times Cited: 27
Long‐term first‐in‐man Phase I/II study of an adjuvant dendritic cell vaccine in patients with high‐risk prostate cancer after radical prostatectomy
Anne Merete Tryggestad, Karol Axcrona, Ulrika Axcrona, et al.
The Prostate (2021) Vol. 82, Iss. 2, pp. 245-253
Open Access | Times Cited: 21
Membrane tension-mediated stiff and soft tumor subtypes closely associated with prognosis for prostate cancer patients
Dechao Feng, Jie Wang, Xu Shi, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 8
Construction of a cuproptosis‑related lncRNA signature to predict biochemical recurrence of prostate cancer
Zhaojun Yu, Huanhuan Deng, Haichao Chao, et al.
Oncology Letters (2024) Vol. 28, Iss. 5
Open Access | Times Cited: 2
Correlations between tumor mutation burden and immune infiltrates and their prognostic value in pancreatic cancer by bioinformatic analysis
Yifan Cai, Xuan Wang, Nan Wang, et al.
Life Sciences (2021) Vol. 277, pp. 119505-119505
Closed Access | Times Cited: 16
Identification of Ferroptosis-Associated Genes in Prostate Cancer by Bioinformatics Analysis
Qijun Wo, Zhenghong Liu, Linyi Hu
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 11
Holliday Cross-Recognition Protein HJURP: Association With the Tumor Microenvironment in Hepatocellular Carcinoma and With Patient Prognosis
Dongcheng Luo, Sina Liao, Yu Liu, et al.
Pathology & Oncology Research (2022) Vol. 28
Open Access | Times Cited: 9
CHRDL1, NEFH, TAGLN and SYNM as novel diagnostic biomarkers of benign prostatic hyperplasia and prostate cancer
Zhiyong Su, Guanghui Wang, Leilei Li
Cancer Biomarkers (2023) Vol. 38, Iss. 2, pp. 143-159
Closed Access | Times Cited: 5
Understanding the tumor-immune microenvironment in prostate cancer
Liang Dong, K. Myers, Kenneth J. Pienta
Current Opinion in Oncology (2021) Vol. 33, Iss. 3, pp. 231-237
Closed Access | Times Cited: 11
Mutational landscape of cancer and how latest technologies can help in simplifying the understanding
Sameer Deshmukh, Aysswarya Manoharan, Sharada Devi J N, et al.
Elsevier eBooks (2024), pp. 141-171
Closed Access | Times Cited: 1
Identification of crucial genes and pathways associated with prostate cancer in multiple databases
Hanxu Guo, Zhichao Zhang, Yuhang Wang, et al.
Journal of International Medical Research (2021) Vol. 49, Iss. 6
Open Access | Times Cited: 10
Inflammation-related signature for prognostic prediction, tumor immune, genomic heterogeneity, and drug choices in prostate cancer: Integrated analysis of bulk and single-cell RNA-sequencing
Weian Zhu, Jiongduan Huang, Jianjie Wu, et al.
Heliyon (2023) Vol. 9, Iss. 11, pp. e21174-e21174
Open Access | Times Cited: 3
Chemokine- and chemokine receptor-based signature predicts immunotherapy response in female colorectal adenocarcinoma patients
Wenjie Zhu, Changlei Wu, Shiqi Hu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 3
Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target
Guangzhao Huang, Ze-qun Chen, Juan Wu, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-27
Open Access | Times Cited: 7
Establishment of a novel prognostic prediction model through bioinformatics analysis for prostate cancer based on ferroptosis-related genes and its application in immune cell infiltration
Boyu Yang, Meishan Zhao, Mingjun Shi, et al.
Translational Andrology and Urology (2022) Vol. 11, Iss. 8, pp. 1130-1147
Open Access | Times Cited: 5
Mining The Cancer Genome Atlas database for tumor mutation burden and its clinical implications in gastric cancer
Dongyan Zhao, Xizhen Sun, Shukun Yao
World Journal of Gastrointestinal Oncology (2021) Vol. 13, Iss. 1, pp. 37-57
Open Access | Times Cited: 6
ENOX1, CCDC122ANDLACC1ROLE IN PROGRESSION OF PROSTATE CANCER
Timothy Ongaba
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 2
The Clinical Impact of Death Domain-Associated Protein and Holliday Junction Recognition Protein Expression in Cancer: Unmasking the Driving Forces of Neoplasia
Alexandros Pergaris, Ioannis Genaris, Ioanna Ε. Stergiou, et al.
Cancers (2023) Vol. 15, Iss. 21, pp. 5165-5165
Open Access | Times Cited: 2
Identification and validation of RB1 as an immune-related prognostic signature based on tumor mutation burdens in bladder cancer
Ning Liu, Tiange Wu, Yuexian Ma, et al.
Anti-Cancer Drugs (2022)
Open Access | Times Cited: 4
Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer
Shan Hua, Zhiwen Xie, Wenhao Wang, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 4
LAMP5, One of Four Genes Related to Oxidative Stress That Predict Biochemical Recurrence-Free Survival, Promotes Proliferation and Invasion in Prostate Cancer
Peiqiang Wu, Jianlei Zhang, Li Guo, et al.
Advances and Applications in Bioinformatics and Chemistry (2024) Vol. Volume 17, pp. 119-138
Open Access
Analysis of transcriptomic data reveals the landscape of cholesterol metabolism in prostate cancer and impact of related signature on survival
Jian‐Xuan Sun, Ye An, Mengyao Xu, et al.
Discover Oncology (2024) Vol. 15, Iss. 1
Open Access
Page 1 - Next Page

Scroll to top